3D Printed Breast Models in the Surgical Management of Breast Cancer

Sponsor
M.D. Anderson Cancer Center (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05755984
Collaborator
University Cancer Foundation via the Institutional Research Grant program at the University of Texas MD Anderson Cancer Center (Other)
200
1
2
43
4.7

Study Details

Study Description

Brief Summary

To learn if providing a 3-D printed model of the breast can help breast cancer patients make decisions related to their care. During this study, some study participants will receive the 3-D printed model and some study participants will receive traditional breast imaging scans to learn if the 3-D printed model

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: 3D printed model
Phase 2

Detailed Description

Primary Objective:

•The objective of this prospective study is to determine the impact of 3D printed breast models, compared to 2D imaging, on breast cancer patients' decisional conflict related to treatment decision-making.

Secondary Objective:
  • To observe if patients will change their initial desired surgical option (mastectomy versus lumpectomy) after viewing the 3D printed models

  • To evaluate the quality of the communication between surgical providers and patients with and without the 3D printed models

  • To assess the surgical outcome including the margin status

  • To evaluate patient satisfaction and well-being post-surgery between the 3D printed model group and the control group as well as mastectomy versus lumpectomy subgroups

  • To assess surgical providers' response to the acceptability and utility of the model

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
3D Printed Breast Models in the Surgical Management of Breast Cancer
Anticipated Study Start Date :
Jul 31, 2023
Anticipated Primary Completion Date :
Feb 28, 2025
Anticipated Study Completion Date :
Feb 28, 2027

Arms and Interventions

Arm Intervention/Treatment
Experimental: Arm 1: 3D printed model

a 3-D printed model of your breast will be created and discussed with participants during your surgical consultation.

Diagnostic Test: 3D printed model
scan

No Intervention: Arm 2: No 3D printed model

Participants will have a standard-of-care surgical consultation using traditional breast imaging.

Outcome Measures

Primary Outcome Measures

  1. Decision Conflict Scale (DCS) score questionnaires [through study completion; an average of 1 year.]

    Score scale ranges: Strongly Agree 1, Agree 2 Neither agree or Agree 3 Strongly Disagree 4

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 18 or older female

  • Patient must have histologically confirmed breast malignancy

  • Patient is a candidate for surgical management

  • Patient has a surgeon at MDACC (main campus and/or Houston Area Locations)

  • Patient has a breast MRI for extent of disease assessment at MDACC (main campus and/or Houston Area Locations).

  • Patient is able to speak, read or write English

  • Patient is willing to be randomized to the control or 3D printed breast model groups and is willing to sign the consent form.

Exclusion Criteria:
  • Pregnant and breastfeeding patients

  • Patients who had history of mastectomy, have recurrent malignancies on the mastectomy side

  • Patients for whom it is not feasible to create a 3D printed breast model from breast MRI

Contacts and Locations

Locations

Site City State Country Postal Code
1 M D Anderson Cancer Center Houston Texas United States 77030

Sponsors and Collaborators

  • M.D. Anderson Cancer Center
  • University Cancer Foundation via the Institutional Research Grant program at the University of Texas MD Anderson Cancer Center

Investigators

  • Principal Investigator: Lauren Chang Sen, MD, M.D. Anderson Cancer Center

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT05755984
Other Study ID Numbers:
  • 2021-1201
  • NCI-2023-01852
First Posted:
Mar 6, 2023
Last Update Posted:
Mar 6, 2023
Last Verified:
Feb 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 6, 2023